GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing multiplex molecular diagnostic solutions. Co. develops and commercializes instruments and multiplex molecular panels based on its proprietary eSensor electrochemical detection technology. Co.'s technologies include: eSensor technology, which is based on the principles of deoxyribonucleic acid, hybridization and electrochemical detection; and digital microfluidics, which is a technique for moving small droplets of liquid using electrowetting, a process for making a surface hydrophobic or hydrophilic based on the application of a voltage to a surface. We show 41 historical shares outstanding datapoints in our GNMK shares outstanding history coverage, used to compute GNMK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GNMK market cap history over the course of time is important for investors
interested in comparing GNMK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GNMK versus a peer is one thing; comparing
GNMK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GNMK can fluctuate over the course of history.
With this page we aim to empower investors researching GNMK by allowing them to research the GNMK market cap history. |
Free GNMK Email Alerts:
Video: The Importance of Market Cap
